- Home
- PRTS vs PEPG Comparison
PRTS vs PEPG Comparison
Compare PRTS & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTS
- PEPG
- Stock Information
- Founded
- PRTS 1995
- PEPG 2018
- Country
- PRTS United States
- PEPG United States
- Employees
- PRTS N/A
- PEPG N/A
- Industry
- PRTS Auto & Home Supply Stores
- PEPG Biotechnology: Pharmaceutical Preparations
- Sector
- PRTS Consumer Discretionary
- PEPG Health Care
- Exchange
- PRTS Nasdaq
- PEPG Nasdaq
- Market Cap
- PRTS 47.8M
- PEPG 52.4M
- IPO Year
- PRTS 2007
- PEPG 2022
- Fundamental
- Price
- PRTS $0.91
- PEPG $1.53
- Analyst Decision
- PRTS Buy
- PEPG Buy
- Analyst Count
- PRTS 3
- PEPG 3
- Target Price
- PRTS $1.60
- PEPG $9.67
- AVG Volume (30 Days)
- PRTS 527.5K
- PEPG 225.9K
- Earning Date
- PRTS 05-13-2025
- PEPG 05-08-2025
- Dividend Yield
- PRTS N/A
- PEPG N/A
- EPS Growth
- PRTS N/A
- PEPG N/A
- EPS
- PRTS N/A
- PEPG N/A
- Revenue
- PRTS $588,846,000.00
- PEPG N/A
- Revenue This Year
- PRTS $1.27
- PEPG N/A
- Revenue Next Year
- PRTS $6.16
- PEPG N/A
- P/E Ratio
- PRTS N/A
- PEPG N/A
- Revenue Growth
- PRTS N/A
- PEPG N/A
- 52 Week Low
- PRTS $0.68
- PEPG $0.88
- 52 Week High
- PRTS $1.45
- PEPG $19.30
- Technical
- Relative Strength Index (RSI)
- PRTS 52.36
- PEPG 51.39
- Support Level
- PRTS $0.80
- PEPG $1.46
- Resistance Level
- PRTS $1.05
- PEPG $1.66
- Average True Range (ATR)
- PRTS 0.07
- PEPG 0.17
- MACD
- PRTS 0.00
- PEPG 0.02
- Stochastic Oscillator
- PRTS 44.00
- PEPG 70.37
About PRTS CarParts.com Inc.
CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. It serves as an end-to-end solution for automotive repair and maintenance resources, offering a seamless online shopping experience that empowers drivers along every part of their journey. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.